Kamyar Kalantar-Zadeh M.D. to Cholesterol, LDL
This is a "connection" page, showing publications Kamyar Kalantar-Zadeh M.D. has written about Cholesterol, LDL.
Connection Strength
1.308
-
Association of serum lipids with outcomes in Hispanic hemodialysis patients of the West versus East Coasts of the United States. Am J Nephrol. 2015; 41(4-5):284-95.
Score: 0.474
-
Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients. Clin J Am Soc Nephrol. 2011 Dec; 6(12):2861-70.
Score: 0.370
-
Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients. Am J Kidney Dis. 2015 Aug; 66(2):313-21.
Score: 0.117
-
Role of HDL dysfunction in end-stage renal disease: a double-edged sword. J Ren Nutr. 2013 May; 23(3):203-6.
Score: 0.103
-
Dietary intake in hemodialysis patients does not reflect a heart healthy diet. J Ren Nutr. 2011 Nov; 21(6):438-47.
Score: 0.087
-
A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controls. Hemodial Int. 2005 Jul; 9(3):314-24.
Score: 0.060
-
The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: overview of the NIED study and the role of dietitians. J Ren Nutr. 2005 Apr; 15(2):231-43.
Score: 0.059
-
Effect of selective BET protein inhibitor apabetalone on cardiovascular outcomes in patients with acute coronary syndrome and diabetes: Rationale, design, and baseline characteristics of the BETonMACE trial. Am Heart J. 2019 11; 217:72-83.
Score: 0.040